Stock
(Reuters) – Drugmaker Biogen (NASDAQ:BIIB) will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece, a filing...
Hi, what are you looking for?
(Reuters) – Meta (NASDAQ:META) CEO Mark Zuckerberg met with U.S. President-elect Donald Trump at Mar-a-Lago on Friday, Semafor news website reported, citing a source...
(Reuters) – Drugmaker Biogen (NASDAQ:BIIB) will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece, a filing...
WASHINGTON (Reuters) -Taiwan Semiconductor Manufacturing Co has begun producing advanced 4-nanometer chips for U.S. customers in Arizona, Commerce Secretary Gina Raimondo told Reuters, a...
BEIJING (Reuters) – China’s stimulus efforts could come with a cost and they must be carried out alongside reforms to ensure sustainable economic growth,...
WASHINGTON (Reuters) – Republican U.S. presidential candidate Donald Trump said on Tuesday the European Union would have to “pay a big price” for not...
BERLIN (Reuters) – The number of people out of work in Germany rose more than expected in October, federal labour office figures showed on...
By Yadarisa Shabong and Maggie Fick (Reuters) -GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its...
Investing.com — US stock futures edge higher ahead of wave of corporate earnings and a key release of US growth figures for the third...